CBER Pilot Seeks To Improve Use Of Electronic Datasets
This article was originally published in The Pink Sheet Daily
Sponsors are asked to volunteer to evaluate tools used to analyze nonclincial and clinical electronic datasets. FDA expects to recommend detailed standards for the submission of animal and human data.
You may also be interested in...
HHS Medical Innovation Task Force report says CMS will assist FDA in postmarketing drug surveillance. The collaboration also includes parallel reviews by the two agencies to minimize delays between marketing approval and reimbursement.
The U.S. Global AIDS Coordinator's Office suggests it will use its authority to purchase an FDA-approved generic antiretroviral product for which permission could not be obtained from the patent holder. FDA grants tentative approval to a South African firm for a generic co-packaged version of Combivir and Viramune.